Finance

Lists
POLYMED:NSE
Poly Medicure Ltd.
1 579,30 INR
-1,29%
(-20,70) 1D
14 ოქტ, 15:30:00 GMT+5:30  ·   INR
All symbols
SymbolPriceChange% Change
Generating top insights for POLYMED...
Open
1 600,00 INR
High
1 608,40 INR
Low
1 575,50 INR
Mkt. cap
159,95 მლრ.
Avg. vol.
136,33 ათ.
Volume
68,56 ათ.
Dividend
0,22%
Quarterly dividend
0,87 INR
Ex-dividend date
28 აგვ. 2026
P/E ratio
50,84
52-wk high
2 094,30 INR
52-wk low
1 182,00 INR
EPS
31,06 INR
Shares outstanding
88,23 მლნ.
No. of employees
3 ათ.
Open
1 600,00 INR
High
1 608,40 INR
Low
1 575,50 INR
Mkt. cap
159,95 მლრ.
Avg. vol.
136,33 ათ.
Volume
68,56 ათ.
Dividend
0,22%
Quarterly dividend
0,87 INR
Ex-dividend date
28 აგვ. 2026
P/E ratio
50,84
52-wk high
2 094,30 INR
52-wk low
1 182,00 INR
EPS
31,06 INR
Shares outstanding
88,23 მლნ.
No. of employees
3 ათ.
News stories
From web sources and news partners
About Poly Medicure Ltd.
CEO-
Employees2,61 ათ.
Founded1995
Headquarters-
SectorMedical device
Last report
10 აგვ. 2026
Fiscal period
Q1 2027
8,48 INR / 7,08 INR
+19,86%beat
Revenue / Est. (INR)
5,25 მლრდ. / 5,27 მლრდ.
-0,22%miss
Fiscal Q1 2027 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in INR
Loading Previous Earnings...
Revenue
Net income
All values in INR
სექ. 2025
დეკ. 2025
მარ. 2026
ივნ. 2026
Revenue
4,44 მლრდ.
4,94 მლრდ.
5,35 მლრდ.
5,25 მლრდ.
Cost of goods sold
1,36 მლრდ.
1,56 მლრდ.
1,84 მლრდ.
1,40 მლრდ.
Cost of revenue
1,36 მლრდ.
1,56 მლრდ.
1,84 მლრდ.
1,40 მლრდ.
Research and development expenses
78,06 მლნ.
59,58 მლნ.
94,31 მლნ.
78,91 მლნ.
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
888,26 მლნ.
1,15 მლრდ.
1,33 მლრდ.
1,27 მლრდ.
Operating expense
2,18 მლრდ.
2,55 მლრდ.
2,76 მლრდ.
2,97 მლრდ.
Total operating expenses
3,54 მლრდ.
4,11 მლრდ.
4,60 მლრდ.
4,37 მლრდ.
Operating income
897,54 მლნ.
824,27 მლნ.
744,05 მლნ.
888,45 მლნ.
Other non operating income
339,44 მლნ.
262,63 მლნ.
-866,83 მლნ.
334,09 მლნ.
EBT including unusual items
1,22 მლრდ.
976,12 მლნ.
852,22 მლნ.
1,17 მლრდ.
EBT excluding unusual items
1,22 მლრდ.
1,04 მლრდ.
326,10 მლნ.
1,17 მლრდ.
Income tax expense
298,93 მლნ.
268,04 მლნ.
201,81 მლნ.
320,31 მლნ.
Effective tax rate
24,56%
27,46%
23,68%
27,31%
Other operating expenses
969,06 მლნ.
1,06 მლრდ.
945,74 მლნ.
1,26 მლრდ.
Net income
918,35 მლნ.
709,30 მლნ.
662,92 მლნ.
860,25 მლნ.
Net profit margin
20,69%
14,37%
12,40%
16,37%
Earnings per share
9,06
7,48
6,53
8,48
Interest and investment income
-
-
112,07 მლნ.
-
Interest expense
-29,73 მლნ.
-59,59 მლნ.
-66,04 მლნ.
-65,01 მლნ.
Net interest expenses
-29,73 მლნ.
-59,59 მლნ.
46,04 მლნ.
-65,01 მლნ.
Depreciation and amortization charges
249,31 მლნ.
287,56 მლნ.
385,72 მლნ.
362,53 მლნ.
EBITDA
1,14 მლრდ.
1,03 მლრდ.
1,02 მლრდ.
1,18 მლრდ.
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
Google აპები